J.R. Germà

Risk-Adapted Management for Patients With Clinical Stage I Seminoma: The Second Spanish Germ Cell Cancer Cooperative Group Study

Jorge Aparicio, J.R. Germà, Xavier García del Muro et al. · Journal of Clinical Oncology · 2005 · 231 citations

Risk-Adapted Treatment in Clinical Stage I Testicular Seminoma: The Third Spanish Germ Cell Cancer Group Study

Jorge Aparicio, Pablo Maroto, Xavier García del Muro et al. · Journal of Clinical Oncology · 2011 · 127 citations · Full text

Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma

Jorge Aparicio, Xavier García del Muro, Pablo Maroto et al. · Annals of Oncology · 2003 · 126 citations · Full text

Clinical Stage, Dual Policy, Surgical Oncology +8

Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)

Jorge Aparicio, Pablo Maroto, Xavier García del Muro et al. · Annals of Oncology · 2014 · 122 citations · Full text

Prognostic Factors, Risk-adapted Studies, Urology +9

Clinicopathological risk factors of Stage II colon cancer: results of a prospective study

Cristina Santos, Adriana López‐Doriga, M. Navarro et al. · Colorectal Disease · 2012 · 40 citations